ART with long-term effects without immunosuppression

Published Date: 02 Mar 2023

The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.

Read Full News

Latest News

Stinky socks help replace human bait in surveys for river blindness

New research shows that it's possible to end the practice of using people as human bait to catch and test the black flies that spread river blindness (onchocerciasis). The study by international non‐profit Sightsavers in ...

Two drugs that treat prostate cancer may also be effective against leukemia

Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study by researchers at Penn State. AML, a cancer of blood ...

Q&A: Why experts urge continued hepatitis B vaccine birth doses for newborns

In a commentary published in Gastroenterology, leading experts urge that all newborns in the United States continue to receive the first dose of hepatitis B vaccine within 24 hours of birth.

COP30 report reveals how climate change is spreading infectious diseases to new regions

Rising temperatures, changing rainfall patterns and extreme weather events create ideal conditions for pathogens and their vectors—such as mosquitoes, midges and ticks—to thrive.

Headaches affect almost a third of people worldwide

Do you have regular migraine headaches? If so, you've got a lot of company.

Ethiopia investigates possible outbreak of new viral hemorrhagic fever after 8 people are infected

African health authorities on Thursday confirmed a possible outbreak of an unidentified viral hemorrhagic fever in southern Ethiopia that is under investigation after eight suspected cases were reported.

Todays Updates

Cancer care crowdfunding increasingly common, but rarely successful

A growing number of desperate cancer survivors are turning to crowdfunding to help pay for their treatment and living expenses, a new study says.

Traces of bacteria inside brain tumors may affect tumor behavior

Researchers at The University of Texas MD Anderson Cancer Center have uncovered unexpected traces of bacteria within brain tumors. This discovery offers new insights into the environment in which brain tumors grow and sets ...

Todays Updates

Cancer care crowdfunding increasingly common, but rarely successful

A growing number of desperate cancer survivors are turning to crowdfunding to help pay for their treatment and living expenses, a new study says.

Traces of bacteria inside brain tumors may affect tumor behavior

Researchers at The University of Texas MD Anderson Cancer Center have uncovered unexpected traces of bacteria within brain tumors. This discovery offers new insights into the environment in which brain tumors grow and sets ...

Latest News

New research shows that it's possible to end the practice of using people as human bait to catch and test the black flies that spread river blindness (onchocerciasis). The study by international non‐profit Sightsavers in ...

Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study by researchers at Penn State. AML, a cancer of blood ...

In a commentary published in Gastroenterology, leading experts urge that all newborns in the United States continue to receive the first dose of hepatitis B vaccine within 24 hours of birth.

Rising temperatures, changing rainfall patterns and extreme weather events create ideal conditions for pathogens and their vectors—such as mosquitoes, midges and ticks—to thrive.

Do you have regular migraine headaches? If so, you've got a lot of company.

African health authorities on Thursday confirmed a possible outbreak of an unidentified viral hemorrhagic fever in southern Ethiopia that is under investigation after eight suspected cases were reported.

News All Time

Halting pancreatic cancer spread: Protein-degrading drugs show promise in preclinical models

Last year, researchers at the University of California, Riverside, developed a novel "molecular crowbar" strategy to degrade the oncogenic enzyme Pin1, a protein that is overexpressed in many tumors, including pancreatic ...

New study reveals long-term impacts on Stevens-Johnson syndrome survivors

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) survivors encounter rare, life-threatening drug reactions and years of physical, emotional and social consequences long after leaving the hospital, according ...

Headache disorders affect 3 billion people worldwide, ranking sixth for health loss in 2023

Headache disorders affected almost 3 billion people worldwide in 2023—nearly one in every three people, a figure unchanged since 1990—and ranked sixth among causes of health loss, according to new research to be published ...

Clinical trial finds single-dose combination malaria treatment as effective as multi-day, multi-dose regimen

Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose of a treatment that utilizes four widely available malaria drugs, according to a new study presented ...

Self-reactive T cells may explain why some patients can't reach undetectable HIV levels

Despite the capability of antiretroviral drugs to suppress HIV to undetectable levels, some people living with the human immunodeficiency virus can't reach the goal of viral imperceptibility even with daily doses of the potent ...

Men, women face different challenges with COPD, bronchiectasis, and NTM lung disease

Men and women with chronic obstructive pulmonary disease (COPD), bronchiectasis, and nontuberculous mycobacterial (NTM) lung disease report differences in symptoms, mental health, disease burden, and other patient-reported ...

Human gene PARP14 could be novel target for viral diseases or immune-mediated disorders

Researchers at the University of Kansas have discovered a human gene, the protein PARP14, plays a role in regulating interferon, part of the body's innate immune system. Their study, appearing in the journal mBio, could guide ...

Multiple sclerosis explained: Symptoms, risk factors and treatments

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million people estimated to be living with the disease worldwide.

Gene therapy for sickle cell and β-thalassemia works by disrupting three-dimensional genome structure

Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment opportunity for sickle cell disease and β-thalassemia. The discovery, published in Blood, is based ...

Long COVID: Resistance exercise can improve physical and mental symptoms

A three-month program of resistance exercise can help improve the physical and mental well-being of people with long COVID, according to newly published research.

I have a stuffy nose. How do I know if it's hay fever or a cold?

You've been through winter lurgies and escaped the start of spring free of hay fever. Now you wake up with a sniffle you can't seem to shake.

New immune response patterns for tuberculosis discovered outside the lungs

Tuberculosis (TB) is one of the world's most common infectious diseases. Although infection with the Mycobacterium tuberculosis bacterium primarily affects the lungs, up to 25% of all infected people will also have it in ...

Unfolding the truth about bladder function: New insights into how the organ actually works

According to researcher Anne Robertson, the bladder is not considered a particularly glamorous organ, despite hosting many of the same physiological elements and processes as the heart.

Canada loses its official 'measles-free' status, and the US will follow soon, as vaccination rates fall

In the wake of a measles outbreak in Canada that has infected thousands of people over the past year, an international health agency revoked the country's measles-free status on Nov. 10, 2025.

AI beats traditional methods in prison-community disease control

Stanford Health Policy researchers built a model to test whether AI could effectively manage disease spread between prisons and surrounding communities. The results were decisive.

Sodium bicarbonate fails to boost survival in patients with severe acidemia

Montpellier University Hospital leads a 43-center French effort that reports no reduction in day 90 all-cause mortality with sodium bicarbonate infusion for critically ill adults with severe metabolic acidemia and moderate ...

Recommended News For You

Novel Drugs Boost Immunotherapy Activity in Resectable Lung Cancer

Recent Rise in Early-Onset Solid Tumors Is Associated with Accelerated Aging.

Hemihedral resection not necessary for neuroendocrine surgery after appendicitis

Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

New CAR T-Cell Therapy Approved for Leukemia

The White House has postponed its plan to outlaw menthol cigarettes indefinitely.

Minimally invasive prostate cancer treatment shows success in first patient

Recommended Articles For You

CENP-H in Cancer: A Key Player in Tumor Progression and a Potential Therapeutic Target 

Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer 

Hepatocellular Carcinoma: Progress in Detection, Pathogenesis, and Treatment 

A Visual Guide to Understanding Breast Cancer Staging 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Compared to previous estimates, a greater number of patients participate in cancer treatment trials.

2.

Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.

3.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

4.

Stevia leaf extract has potential as anticancer treatment, researchers find

5.

CAR Natural Killer Cell Therapy Shows Promise in B-Cell Lymphomas

1.

Revolutionizing Cancer Treatment with Darzalex: How an Innovative Drug is Transforming Lives

2.

Cancer in 2024: Global Trends, Challenges, and Innovations for Healthcare Professionals

3.

Understanding QSOFA: A Vital Tool for Recognizing Sepsis 

4.

An Overview Of Daunorubicin: What Is It Used For And How Does It Work?

5.

Understanding the Importance of Knowing Your MCV Normal Range

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

4.

Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot